phobic disorder |
Disease ID | 1107 |
---|---|
Disease | phobic disorder |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:2) |
Disease ID | 1107 |
---|---|
Disease | phobic disorder |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:5) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1256049 | 21570196 | 2100 | ESR2 | umls:C0349231 | BeFree | The A allele of ESR2 rs1256049 was associated with an increased risk of GAD [OR: 2.06, 95% CI: 1.09-3.87], while both ESR1 polymorphisms were specifically associated with phobia. | 0.000271442 | 2011 | ESR2 | 14 | 64257333 | C | T |
rs4680 | 15450911 | 4128 | MAOA | umls:C0349231 | BeFree | Functional polymorphisms in the MAO-A uVNTR promoter gene, the COMT gene (Val158Met) exon 4, and the 5-HTT promoter gene (44 bp ins/del) were investigated in 101 patients with phobic disorders of the anxiety spectrum and 202 controls matched to the patients for sex, age and ethnicity. | 0.000271442 | 2004 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 15450911 | 6532 | SLC6A4 | umls:C0349231 | BeFree | Functional polymorphisms in the MAO-A uVNTR promoter gene, the COMT gene (Val158Met) exon 4, and the 5-HTT promoter gene (44 bp ins/del) were investigated in 101 patients with phobic disorders of the anxiety spectrum and 202 controls matched to the patients for sex, age and ethnicity. | 0.000271442 | 2004 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 15450911 | 1312 | COMT | umls:C0349231 | BeFree | Functional polymorphisms in the MAO-A uVNTR promoter gene, the COMT gene (Val158Met) exon 4, and the 5-HTT promoter gene (44 bp ins/del) were investigated in 101 patients with phobic disorders of the anxiety spectrum and 202 controls matched to the patients for sex, age and ethnicity. | 0.002638474 | 2004 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs5751876 | 20334879 | 135 | ADORA2A | umls:C0349231 | BeFree | A variant within the corresponding ADORA2A gene (rs5751876) increased the risk for panic disorder (PD), for elevated anxiety during challenge tests in healthy probands and for anxiety-related arousal in blood-injury phobia. | 0.000271442 | 2010 | ADORA2A;ADORA2A-AS1;SPECC1L-ADORA2A | 22 | 24441333 | T | C |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:7) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0349231 | alprazolam | D000525 | 28981-97-7 | phobic disorders | MESH:D010698 | therapeutic | 3348461 | ||
C0349231 | citalopram | D015283 | 59729-33-8 | phobic disorders | MESH:D010698 | therapeutic | 18208904 | ||
C0349231 | clozapine | D003024 | 5786-21-0 | phobic disorders | MESH:D010698 | marker/mechanism | 10665627 | ||
C0349231 | fluoxetine | D005473 | 54910-89-3 | phobic disorders | MESH:D010698 | therapeutic | 10665627 | ||
C0349231 | haloperidol | D006220 | 52-86-8 | phobic disorders | MESH:D010698 | marker/mechanism | 6946714 | ||
C0349231 | lorazepam | D008140 | 846-49-1 | phobic disorders | MESH:D010698 | marker/mechanism | 1544008 | ||
C0349231 | modafinil | C048833 | 68693-11-8 | phobic disorders | MESH:D010698 | therapeutic | 12411237 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |